KR20220154918A - Cosmetic composition containing Cudrania extract as an active ingredient - Google Patents
Cosmetic composition containing Cudrania extract as an active ingredient Download PDFInfo
- Publication number
- KR20220154918A KR20220154918A KR1020210062463A KR20210062463A KR20220154918A KR 20220154918 A KR20220154918 A KR 20220154918A KR 1020210062463 A KR1020210062463 A KR 1020210062463A KR 20210062463 A KR20210062463 A KR 20210062463A KR 20220154918 A KR20220154918 A KR 20220154918A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- red ginseng
- cudrania
- composition containing
- cosmetic composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 239000002537 cosmetic Substances 0.000 title claims abstract description 31
- 241000218211 Maclura Species 0.000 title claims description 33
- 239000004480 active ingredient Substances 0.000 title claims description 15
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 48
- 235000004433 Simmondsia californica Nutrition 0.000 claims abstract description 41
- 239000000706 filtrate Substances 0.000 claims abstract description 41
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 34
- 241000221095 Simmondsia Species 0.000 claims description 35
- 238000000855 fermentation Methods 0.000 claims description 31
- 230000004151 fermentation Effects 0.000 claims description 31
- 235000008708 Morus alba Nutrition 0.000 claims description 26
- 240000000249 Morus alba Species 0.000 claims description 26
- 241000186660 Lactobacillus Species 0.000 claims description 21
- 229940039696 lactobacillus Drugs 0.000 claims description 21
- 239000000047 product Substances 0.000 claims description 6
- 229940069774 quince extract Drugs 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 230000002087 whitening effect Effects 0.000 abstract description 18
- 244000097654 Cudrania tricuspidata Species 0.000 abstract description 6
- 235000010918 Cudrania tricuspidata Nutrition 0.000 abstract description 6
- 244000044822 Simmondsia californica Species 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000037331 wrinkle reduction Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 35
- 210000003491 skin Anatomy 0.000 description 26
- 238000002360 preparation method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 230000037303 wrinkles Effects 0.000 description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 4
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 4
- PBFGMXZRJIUGKU-UHFFFAOYSA-N 3-decanoyloxybutyl decanoate Chemical compound CCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCC PBFGMXZRJIUGKU-UHFFFAOYSA-N 0.000 description 4
- LFESLSYSZQYEIZ-UHFFFAOYSA-N 3-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCC LFESLSYSZQYEIZ-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 229920002498 Beta-glucan Polymers 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229920002367 Polyisobutene Polymers 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 229940114374 butylene glycol dicaprylate Drugs 0.000 description 4
- 229960001631 carbomer Drugs 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 229930182478 glucoside Natural products 0.000 description 4
- 150000008131 glucosides Chemical class 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 229940047670 sodium acrylate Drugs 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 4
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 229960000281 trometamol Drugs 0.000 description 4
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 3
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 102000016387 Pancreatic elastase Human genes 0.000 description 3
- 108010067372 Pancreatic elastase Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241001135917 Vitellaria paradoxa Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000001153 anti-wrinkle effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 229940081733 cetearyl alcohol Drugs 0.000 description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- -1 serum Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229940096998 ursolic acid Drugs 0.000 description 3
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 2
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 2
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002849 elastaseinhibitory effect Effects 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 description 2
- 229940107131 ginseng root Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940100515 sorbitan Drugs 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229960005559 sulforaphane Drugs 0.000 description 2
- 235000015487 sulforaphane Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229940066528 trichloroacetate Drugs 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- SPMCUTIDVYCGCK-IIIGWGBSSA-N (2s,3r,4s,5r,6r)-2-[(2r,3r,4r,5s)-3,5-dihydroxy-2-(hydroxymethyl)oxan-4-yl]oxy-4-[(2s,3r,5s,6r)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-3,5-diol Chemical compound O[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)OC[C@@H]2O)O)O[C@H](CO)[C@H]1O SPMCUTIDVYCGCK-IIIGWGBSSA-N 0.000 description 1
- NLMOYOROJZUUMN-UHFFFAOYSA-N 2,3-dihydroxypropyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO NLMOYOROJZUUMN-UHFFFAOYSA-N 0.000 description 1
- NALUDDWNDBCDQS-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound C(C)C(O)(C(O)CO)CCCCCC.C(C)C(O)(C(O)CO)CCCCCC NALUDDWNDBCDQS-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 241000221094 Simmondsiaceae Species 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- INDXRDWMTVLQID-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO.OCCCCO INDXRDWMTVLQID-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003602 elastase inhibitor Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- JPCBEVHCIJLZFV-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO.CCCCC(O)CO JPCBEVHCIJLZFV-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 화장료 조성물에 관한 것으로, 보다 자세하게는 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물을 포함하여, 피부 미백, 주름개선 등 피부에 이로운 다양한 기능을 갖도록 한 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition, and more particularly, to a cosmetic composition having various functions beneficial to the skin, such as skin whitening and wrinkle improvement, including Cudrania mulberry extract, jojoba seed oil and red ginseng fermented filtrate.
일반적으로 화장품이라 함은 피부의 결점을 가려주고, 피부를 커버하거나, 피부의 특정부위를 강조하기 위한 목적으로 사용되고 있다.In general, cosmetics are used for the purpose of covering skin defects, covering skin, or emphasizing a specific part of skin.
이러한 화장품의 종류로는 베이스메이크업 화장품, 포인트메이크업 화장품 등이 있으며, 베이스메이크업 화장품에는 스킨, 로션, 파운데이션 등이 있고, 포인트메이크업 화장품에는 립스틱, 아이라이너, 아이쉐도우 등이 있다.Types of cosmetics include base makeup cosmetics, point makeup cosmetics, etc. Base makeup cosmetics include skin, lotion, foundation, etc., and point makeup cosmetics include lipstick, eyeliner, eye shadow, and the like.
종래의 화장품들은 주로 피부를 꾸미기 위한 용도 위주로 사용되었으나, 현대로 접어들면서, 피부의 건강이나 미적인 부분에 대한 효과를 갖도록 피부 미백, 주름 개선 등의 기능을 가진 기능성 제품들이 출시되고 있다.Conventional cosmetics were mainly used for decorating the skin, but with the advent of modern times, functional products having functions such as skin whitening and wrinkle improvement are being released to have effects on the health or beauty of the skin.
다만, 기능성 제품을 구성하기 위해서는, 화학성 물질 위주로 구성이 이루어지는 경우가 많았는데, 이와 관련된 제품으로 대한민국 등록특허 제10-2201385호(2021.01.11.공고)에는, "피부 미백용 조성물 및 이를 이용한 미백용 화장품"이 개시된 바 있다. 해당 종래 특허는 설포라판을 이용한 피부 미백용 조성물 및 이를 이용한 미백용 화장품에 관한 것이다.However, in order to configure functional products, the composition is often composed of chemical substances. As a product related to this, Korean Registered Patent No. 10-2201385 (2021.01.11. Notice), "Composition for skin whitening and whitening using the same" Cosmetics for use" has been disclosed. This prior patent relates to a composition for skin whitening using sulforaphane and cosmetics for whitening using the same.
그러나 상기 종래의 피부 미백용 조성물 및 이를 이용한 미백용 화장품은 설포라판 원료를 사용하여 그 함량에 따라 피부에 자극적일 수 있는 바, 보다 안적적인 천연물 위주의 화장료 조성물에 대한 필요성이 커지고 있는 추세이다.However, the conventional skin whitening composition and whitening cosmetics using the same use a sulforaphane raw material and may be irritating to the skin depending on the content thereof, and thus the need for a more safe natural product-oriented cosmetic composition is increasing.
상기와 같은 문제점을 해결하기 위하여, 본 발명은 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물을 포함하여, 피부 미백, 주름개선 등 피부에 이로운 다양한 기능을 갖도록 한 화장료 조성물을 제공하는데 목적이 있다.In order to solve the above problems, an object of the present invention is to provide a cosmetic composition having various functions beneficial to the skin, such as skin whitening and wrinkle improvement, including Cudrania mulberry extract, jojoba seed oil and red ginseng fermented filtrate. .
상기와 같은 목적을 달성하기 위하여, 본 발명은 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물의 혼합물을 포함하는 것을 특징으로 하는 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition containing a Cudrania quince extract as an active ingredient, characterized in that it comprises a mixture of a Cudrania quince extract, jojoba seed oil and red ginseng fermentation filtrate.
또한, 상기 꾸지뽕나무 추출물은 꾸지뽕나무의 껍질 부위를 추출하여 얻어진 꾸지뽕나무껍질 추출물인 것을 특징으로 한다.In addition, the kuji mulberry extract is characterized in that it is obtained by extracting the bark of the cudra mulberry tree extract.
또한, 상기 홍삼발효물은 홍삼을 락토바실러스를 이용해 발효하여 여과한 락토바실러스/홍삼발효여과물인 것을 특징으로 한다.In addition, the red ginseng fermentation product is characterized in that it is a lactobacillus / red ginseng fermentation filtrate obtained by fermenting red ginseng using lactobacillus and filtering it.
또한, 상기 꾸지뽕나무 추출물, 호호바씨오일, 홍삼발효여과물의 혼합물을 포함하여 스킨, 로션, 세럼, 크림 제형으로 제형화된 것을 특징으로 한다.In addition, it is characterized in that it is formulated into a skin, lotion, serum, cream formulation, including a mixture of the kkuji mulberry extract, jojoba seed oil, and red ginseng fermentation filtrate.
본 발명에 따른 꾸지뽕나무껍질 추출물을 유효성분으로 함유하는 화장료 조성물은 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물을 포함하여, 피부 미백, 주름개선 등 피부에 이로운 다양한 기능을 갖는다.The cosmetic composition containing the bark extract of Cudrania mulberry according to the present invention as an active ingredient has various functions beneficial to the skin, such as skin whitening and wrinkle improvement, including the extract of Cudrania mulberry, jojoba seed oil and fermented red ginseng filtrate.
도 1은 실시예 1 내지 2, 비교예 1 내지 9 그리고, 제조예 1에서 제조한 조성물의 피부미백 효과를 나타낸 그래프.
도 2는 실시예 1 내지 2, 비교예 1 내지 9 그리고, 제조예 1에서 제조한 조성물의 주름개선 효과를 나타낸 그래프.
도 3은 실시예 1 내지 2, 비교예 1 내지 9 그리고, 제조예 1에서 제조한 조성물의 안티폴루션 효과를 나타낸 그래프.1 is a graph showing the skin whitening effect of the composition prepared in Examples 1 to 2, Comparative Examples 1 to 9, and Preparation Example 1.
Figure 2 is a graph showing the anti-wrinkle effect of the composition prepared in Examples 1 to 2, Comparative Examples 1 to 9, and Preparation Example 1.
Figure 3 is a graph showing the anti-pollution effect of the composition prepared in Examples 1 to 2, Comparative Examples 1 to 9, and Preparation Example 1.
이하의 본 발명에 관한 상세한 설명들은 본 발명이 실시될 수 있는 실시 예이고 해당 실시 예의 예시로써 도시된 첨부 도면을 참조한다. 이들 실시 예는 당 업자가 본 발명의 실시에 충분하도록 상세히 설명된다. 본 발명의 다양한 실시 예는 서로 다르지만 상호 배타적일 필요는 없음이 이해되어야 한다. 예를 들어, 여기에 기재되어 있는 특정 형상, 구조 및 특성은 일 실시 예에 관련하여 본 발명의 사상 및 범위를 벗어나지 않으면서 다른 실시 예로 구현될 수 있다. 또한, 각각의 기재된 실시 예 내의 개별 구성요소의 위치 또는 배치는 본 발명의 사상 및 범위를 벗어나지 않으면서 변경될 수 있음이 이해되어야 한다.The detailed description of the present invention below refers to the accompanying drawings shown as examples of embodiments in which the present invention can be practiced. These embodiments are described in detail so that those skilled in the art will be able to practice the present invention. It should be understood that the various embodiments of the present invention are different, but need not be mutually exclusive. For example, specific shapes, structures, and characteristics described herein may be implemented in one embodiment in another embodiment without departing from the spirit and scope of the invention. Additionally, it should be understood that the location or arrangement of individual components within each described embodiment may be changed without departing from the spirit and scope of the invention.
따라서 후술되는 상세한 설명은 한정적인 의미로서 취하려는 것이 아니며, 본 발명의 범위는 적절하게 설명된다면 그 청구항들이 주장하는 것과 균등한 모든 범위와 더불어 첨부된 청구항에 의해서만 한정된다. 도면에서 유사한 참조부호는 여러 측면에 걸쳐서 동일하거나 유사한 기능을 지칭한다.Accordingly, the detailed description set forth below is not to be taken in a limiting sense, and the scope of the present invention, if properly described, is limited only by the appended claims, along with all equivalents as claimed by those claims. Like reference numbers in the drawings indicate the same or similar function throughout the various aspects.
본 발명에서 사용되는 용어는 본 발명에서의 기능을 고려하면서 가능한 현재 널리 사용되는 일반적인 용어들을 선택하였으나, 이는 당 분야에 종사하는 기술자의 의도 또는 판례, 새로운 기술의 출현 등에 따라 달라질 수 있다. 또한, 특정한 경우는 출원인이 임의로 선정한 용어도 있으며, 이 경우 해당되는 발명의 설명 부분에서 상세히 그 의미를 기재할 것이다. 따라서 본 발명에서 사용되는 용어는 단순한 용어의 명칭이 아닌, 그 용어가 가지는 의미와 본 발명의 전반에 걸친 내용을 토대로 정의되어야 한다.The terms used in the present invention have been selected from general terms that are currently widely used as much as possible while considering the functions in the present invention, but these may vary depending on the intention of a person skilled in the art or precedent, the emergence of new technologies, and the like. In addition, in a specific case, there is also a term arbitrarily selected by the applicant, and in this case, the meaning will be described in detail in the description of the invention. Therefore, the term used in the present invention should be defined based on the meaning of the term and the overall content of the present invention, not simply the name of the term.
본 발명에서 어떤 부분이 어떤 구성요소를 “포함”한다고 할 때, 이는 특별히 반대되는 기재가 없는 한, 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있음을 의미한다.In the present invention, when a part "includes" a certain component, it means that it may further include other components, not excluding other components, unless otherwise stated.
이하, 본 발명에 따른 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물에 대하여 자세히 설명한다.Hereinafter, the cosmetic composition containing the kkujimul tree extract according to the present invention as an active ingredient will be described in detail.
본 발명에 따른 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물은 꾸지뽕나무 추출물, 호호바씨오일, 홍삼발효여과물의 혼합물을 포함하는 것을 특징으로 한다.The cosmetic composition containing the Cudrania sinensis extract according to the present invention as an active ingredient is characterized by comprising a mixture of Cudrania sinensis extract, jojoba seed oil, and red ginseng fermentation filtrate.
상기 꾸지뽕나무 추출물은 꾸지뽕나무로부터 얻은 추출물을 칭한다. 본 발명에 있어서, 상기 꾸지뽕나무 추출물은 더 자세하게는 꾸지뽕나무의 껍질 부위를 추출하여 얻어진 것이 바람직하다. 상기 꾸지뽕나무(Cudrania tricuspidata (Carriere) Bureau ex Lavallee)는 목련강 쐐기풀목 뽕나무과 꾸지뽕나무속에 속하는 작은키 나무로, 높이는 3-8m이며, 가지에 가시가 있고, 잎은 난형으로 3갈래로 갈라지기도 하며, 길이 6-10cm, 폭 3-6cm, 위쪽이 점차 좁아지다가 끝은 둔해진다. 상기 꾸지뽕나무의 꽃은 5-6월에 암수딴그루에 피며, 수꽃차례는 작은 꽃들이 모여 머리모양을 이루며, 짧고 부드러운 털이 모여 난다.The kkujimul tree extract refers to an extract obtained from the kkujimul tree. In the present invention, the kkujimul tree extract is preferably obtained by extracting the bark of the kkujimul tree in more detail. The Cudrania tricuspidata (Carriere) Bureau ex Lavallee ) is a small tree belonging to the genus Cudrania, 3-8m high, 3-8m tall, with thorns on branches, leaves ovate, sometimes split into 3 parts, 6-10cm long, 3-6cm wide, It gradually narrows at the top and becomes dull at the end. The flowers of the kuji mulberry tree bloom in male and female plants in May-June, and in the male inflorescence, small flowers gather to form a head shape, and short and soft hairs gather.
상기 호호바씨오일은 호호바의 씨앗으로부터 얻은 오일을 칭한다. 상기 호호바(Simmondsia chinensis)는 호호바과(Simmondsiaceae)의 관목으로, 씨에서 기름(액체 왁스 에스터)을 얻기 위하여 재배한다. 상기 호호바는 미국의 애리조나의 사막 지대, 캘리포니아와 멕시코가 원산지다. 상기 호호바씨오일은 INCI명이 SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL로 시중에 유통되고 있으며, 시중에 유통중인 호호바씨오일을 직접 구입하여 이용할 수도 있을 것이다.The jojoba seed oil refers to oil obtained from the seeds of jojoba. The jojoba ( Simmondsia chinensis ) is a shrub of the jojoba family ( Simmondsiaceae ), and is cultivated to obtain oil (liquid wax ester) from seeds. The jojoba is native to the desert regions of Arizona, California and Mexico in the United States. The jojoba seed oil is distributed on the market under the INCI name SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL, and it may be possible to directly purchase and use jojoba seed oil on the market.
상기 홍삼발효여과물은 홍삼을 발효하고 여과하여 얻은 여과물을 칭한다. 보다 구체적으로, 상기 홍삼발효물은 홍삼을 락토바실러스(Lactobacillus) 균주를 이용해 발효하여 여과한 락토바실러스/홍삼발효여과물인 것이 바람직하다. 상기 홍삼은 인삼(eng C. A. Meyer) 재배 적지에서 생산된 좋은 품질의 6년근 수삼을 엄선하여 껍질을 벗기지 않은 상태로 장시간 증기로 쪄서 건조시킨 담황갈색 또는 담적갈색을 띄는 것으로, 인삼의 크기와 모양 등을 따져 1∼5등급으로 분류하여 씻기, 찌기, 건조를 거치면 홍삼으로 변한다. 홍삼은 시중에 유통되고 있어 구하기 용이하며, 락토바실러스 균주 역시 시중에 유통중인 것을 구입하여 이용할 수 있다. 또는, 상기 락토바실러스/홍삼발효여과물은 INCI명이 LACTOBACILLUS/GINSENG ROOT FERMENT FILTRATE로 시중에 유통되고 있으며, 시중에 유통중인 락토바실러스/홍삼발효여과물을 직접 구입하여 이용할 수도 있을 것이다.The red ginseng fermentation filtrate refers to a filtrate obtained by fermenting and filtering red ginseng. More specifically, the red ginseng fermentation product is preferably a lactobacillus/red ginseng fermentation filtrate obtained by fermenting red ginseng using a Lactobacillus strain and filtering it. The red ginseng is a light yellowish brown or light reddish brown color obtained by carefully selecting good quality 6-year-old fresh ginseng produced in suitable areas for ginseng (eng CA Meyer) cultivation, steaming for a long time in an unpeeled state and drying it, and the size and shape of ginseng, etc. It is classified into 1 to 5 grades after washing, steaming, and drying to turn into red ginseng. Red ginseng is distributed on the market and is easy to obtain, and Lactobacillus strains can also be purchased and used on the market. Alternatively, the lactobacillus / red ginseng fermentation filtrate is distributed in the market under the INCI name LACTOBACILLUS / GINSENG ROOT FERMENT FILTRATE, and the lactobacillus / red ginseng fermentation filtrate may be directly purchased and used.
본 발명에 따른 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물은 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물의 혼합물을 포함하며, 이는 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물이 동시에 포함됨을 의미한다.The cosmetic composition containing the Cudrania mulberry extract according to the present invention as an active ingredient includes a mixture of Cudrania mulberry extract, jojoba seed oil, and red ginseng fermentation filtrate, which contains the Cudrania mulberry extract, jojoba seed oil, and red ginseng fermentation filtrate at the same time. it means.
상기 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물의 혼합물은, 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물이 각각 0.01 ~ 50.0 : 0.01 ~ 50.0 : 0.01 ~ 50.0의 중량비로 혼합된 것이 바람직하다.The mixture of the Cudrania mulberry extract, jojoba seed oil and red ginseng fermentation filtrate is preferably a mixture of the Cudrania mulberry extract, jojoba seed oil and red ginseng fermentation filtrate in a weight ratio of 0.01 to 50.0: 0.01 to 50.0: 0.01 to 50.0, respectively.
보다 바람직하게, 상기 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물의 혼합물은, 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물이 각각 34.0 : 33.0 : 33.0의 중량비로 혼합된 것이 가장 바람직하다.More preferably, the mixture of the Cudrania tree extract, jojoba seed oil and red ginseng fermentation filtrate is most preferably a mixture of the Cudrania tree extract, jojoba seed oil and red ginseng fermentation filtrate in a weight ratio of 34.0: 33.0: 33.0, respectively.
본 발명에 따른 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물은 구체적인 실시로, 크림제형일 수 있다. 본 발명에 따른 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물이 스킨, 로션, 세럼, 크림제형일 때의 추가로 포함될 수 있는 구성성분은 하기 표 1에 나타낸 바와 같다. In specific implementation, the cosmetic composition containing the kkujimul tree extract according to the present invention as an active ingredient may be a cream formulation. Components that may be additionally included when the cosmetic composition containing the kkujimul tree extract according to the present invention as an active ingredient in skin, lotion, serum, and cream formulations are shown in Table 1 below.
즉, 본 발명에 따른 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물은 정제수, 글리세린, 카프릴릭/카프릭트라이글리세라이드, 부틸렌글라이콜다이카프릴레이트/다이카프레이트, 베타인, 세테아릴알코올, 1,2-헥산다이올, 호호바씨오일, 시어버터, 꾸지뽕나무껍질추출물, 부틸렌글라이콜, 트레할로오스, 글리세릴스테아레이트, 비즈왁스, 세테아릴올리베이트, 카보머, 트로메타민, 솔비탄올리베이트, 세테아릴글루코사이드, 소듐아크릴레이트/소듐아크릴로일다이메틸타우레이트코폴리머, 폴리아이소부텐, 에틸헥실글리세린, 베타-글루칸, 프로판다이올, 소듐하이알루로네이트, 향료, 다이소듐이디티에이 및 락토바실러스/홍삼발효여과물의 혼합물을 동시에 포함하는 것일 수 있다. 이때, 상기 향료는 멘톨일 수 있다.That is, the cosmetic composition containing the Cudrania sinensis extract according to the present invention as an active ingredient is purified water, glycerin, caprylic / capric triglyceride, butylene glycol dicaprylate / dicaprate, betaine, cetea Lil Alcohol, 1,2-Hexanediol, Jojoba Seed Oil, Shea Butter, Cudrania Bark Extract, Butylene Glycol, Trehalose, Glyceryl Stearate, Beeswax, Cetearyl Olivate, Carbomer, Tromethamine, Sorbitan Olivate, Cetearyl Glucoside, Sodium Acrylate/Sodium Acryloyldimethyltaurate Copolymer, Polyisobutene, Ethylhexylglycerin, Beta-Glucan, Propanediol, Sodium Hyaluronate, It may contain a mixture of fragrance, disodium EDTA, and lactobacillus/red ginseng fermented filtrate at the same time. In this case, the fragrance may be menthol.
이하, 하기의 실시예, 비교예 및 실험예를 통해 본 발명에 따른 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물이 갖는 효과에 대하여 자세히 알아본다.Hereinafter, the effect of the cosmetic composition containing the Cudrania mulberry extract according to the present invention as an active ingredient will be examined in detail through the following Examples, Comparative Examples and Experimental Examples.
실시예Example 1. One. 꾸지뽕나무mulberry tree 추출물, extract, 호호바씨오일jojoba seed oil 및 and 홍삼발효여과물의red ginseng fermentation filtrate 혼합물을 포함하는 조성물의 제조 Preparation of compositions comprising mixtures
하기의 제조과정에 따라, 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물의 혼합물을 포함하는 조성물을 제조하였다.According to the following manufacturing process, a composition containing a mixture of kkuji mulberry extract, jojoba seed oil and red ginseng fermentation filtrate was prepared.
꾸지뽕나무 추출물 34.0중량%, 호호바씨오일 33.0중량%, 홍삼발효여과물 33.0중량%를 원형 비이커에 넣고, 아지믹서를 이용하여 120rpm으로 30분간 교반하여, 조성물을 제조하였다.34.0% by weight of Cudrania extract, 33.0% by weight of jojoba seed oil, and 33.0% by weight of red ginseng fermented filtrate were put in a circular beaker and stirred for 30 minutes at 120 rpm using an Aji mixer to prepare a composition.
실시예Example 2. 2. 꾸지뽕나무껍질Cudrania Bark 추출물, extract, 호호바씨오일jojoba seed oil 및 and 락토바실러스Lactobacillus // 홍삼발효여과물의red ginseng fermentation filtrate 혼합물을 포함하는 조성물 Compositions containing mixtures
하기의 제조과정에 따라, 꾸지뽕나무껍질 추출물, 호호바씨오일 및 락토바실러스/홍삼발효여과물의 혼합물을 포함하는 조성물을 제조하였다.According to the following manufacturing process, a composition containing a mixture of kuji mulberry bark extract, jojoba seed oil, and lactobacillus/red ginseng fermentation filtrate was prepared.
꾸지뽕나무껍질 추출물 34.0중량%, 호호바씨오일 33.0중량%, 락토바실러스/홍삼발효여과물 33.0중량%를 원형 비이커에 넣고, 아지믹서를 이용하여 120rpm으로 30분간 교반하여, 조성물을 제조하였다.34.0% by weight of Cudrania bark extract, 33.0% by weight of jojoba seed oil, and 33.0% by weight of lactobacillus/red ginseng fermented filtrate were placed in a circular beaker and stirred for 30 minutes at 120 rpm using an aji mixer to prepare a composition.
비교예comparative example 1. One. 꾸지뽕나무mulberry tree 추출물만 단독으로 포함하는 조성물 A composition containing only the extract
하기의 제조과정에 따라, 꾸지뽕나무 추출물만 단독으로 포함하는 조성물을 제조하였다.According to the following manufacturing process, a composition containing only the kkuji mulberry extract alone was prepared.
꾸지뽕나무 추출물 34.0중량%를 비이커에 넣고 정제수를 잔량으로 넣은 다음, 아지믹서를 이용하여 120rpm으로 30분간 교반하여, 조성물을 제조하였다.A composition was prepared by putting 34.0% by weight of Cudrania mulberry extract into a beaker, adding purified water as the remaining amount, and then stirring for 30 minutes at 120 rpm using an Aji mixer.
비교예comparative example 2. 2. 꾸지뽕나무껍질Cudrania Bark 추출물만 단독으로 포함하는 조성물 A composition containing only the extract
하기의 제조과정에 따라, 꾸지뽕나무껍질 추출물만 단독으로 포함하는 조성물을 제조하였다.According to the following manufacturing process, a composition containing only the kkujimul bark extract alone was prepared.
꾸지뽕나무껍질 추출물 34.0중량%를 비이커에 넣고 정제수를 잔량으로 넣은 다음, 아지믹서를 이용하여 120rpm으로 30분간 교반하여, 조성물을 제조하였다.A composition was prepared by putting 34.0% by weight of Cudrania bark extract in a beaker, adding purified water as the remaining amount, and then stirring for 30 minutes at 120 rpm using an aji mixer.
비교예comparative example 3. 3. 호호바씨오일만Jojoba seed oil only 단독으로 포함하는 조성물 Compositions containing alone
하기의 제조과정에 따라, 호호바씨오일만 단독으로 포함하는 조성물을 제조하였다.According to the following manufacturing process, a composition containing only jojoba seed oil was prepared.
호호바씨오일 33.0중량%를 비이커에 넣고 정제수를 잔량으로 넣은 다음, 아지믹서를 이용하여 120rpm으로 30분간 교반하여, 조성물을 제조하였다.After putting 33.0% by weight of jojoba seed oil in a beaker and adding the remaining amount of purified water, the mixture was stirred at 120 rpm for 30 minutes using an azimixer to prepare a composition.
비교예comparative example 4. 4. 홍삼발효여과물만Red ginseng fermentation filtrate only 단독으로 포함하는 조성물 Compositions containing alone
하기의 제조과정에 따라, 홍삼발효여과물만 단독으로 포함하는 조성물을 제조하였다.According to the following manufacturing process, a composition containing only the red ginseng fermentation filtrate was prepared.
홍삼발효여과물 33.0중량%를 비이커에 넣고 정제수를 잔량으로 넣은 다음, 아지믹서를 이용하여 120rpm으로 30분간 교반하여, 조성물을 제조하였다.After putting 33.0% by weight of the red ginseng fermented filtrate in a beaker and adding the remaining amount of purified water, the mixture was stirred at 120 rpm for 30 minutes using an Azimixer to prepare a composition.
비교예comparative example 5. 5. 락토바실러스Lactobacillus // 홍삼발효여과물만Red ginseng fermentation filtrate only 단독으로 포함하는 조성물 Compositions containing alone
하기의 제조과정에 따라, 락토바실러스/홍삼발효여과물만 단독으로 포함하는 조성물을 제조하였다.According to the following manufacturing process, a composition containing only the lactobacillus/red ginseng fermented filtrate was prepared.
락토바실러스/홍삼발효여과물 33.0중량%를 비이커에 넣고 정제수를 잔량으로 넣은 다음, 아지믹서를 이용하여 120rpm으로 30분간 교반하여, 조성물을 제조하였다.33.0% by weight of the lactobacillus/red ginseng fermented filtrate was put in a beaker, the remaining amount of purified water was added, and then the mixture was stirred at 120 rpm for 30 minutes using an azimixer to prepare a composition.
제조예manufacturing example 1. One. 꾸지뽕나무껍질Cudrania Bark 추출물, extract, 호호바씨오일jojoba seed oil 및 and 락토바실러스Lactobacillus // 홍삼발효여과물의red ginseng fermentation filtrate 혼합물을 포함하는 containing a mixture 크림제형의creamy 제조 Produce
정제수, 글리세린, 카프릴릭/카프릭트라이글리세라이드, 부틸렌글라이콜다이카프릴레이트/다이카프레이트, 베타인, 세테아릴알코올, 1,2-헥산다이올, 호호바씨오일, 시어버터, 꾸지뽕나무껍질추출물, 부틸렌글라이콜, 트레할로오스, 글리세릴스테아레이트, 비즈왁스, 세테아릴올리베이트, 카보머, 트로메타민, 솔비탄올리베이트, 세테아릴글루코사이드, 소듐아크릴레이트/소듐아크릴로일다이메틸타우레이트코폴리머, 폴리아이소부텐, 에틸헥실글리세린, 베타-글루칸, 프로판다이올, 소듐하이알루로네이트, 향료(멘톨), 다이소듐이디티에이 및 락토바실러스/홍삼발효여과물을 각각 동량의 중량비로 혼합하여 비커에 넣고 아지믹서를 이용하여 120rpm으로 30분간 교반하여, 크림 제형을 제조하였다.Purified water, glycerin, caprylic/capric triglyceride, butylene glycol dicaprylate/dicaprate, betaine, cetearyl alcohol, 1,2-hexanediol, jojoba seed oil, shea butter, Cudrania Bark Extract, Butylene Glycol, Trehalose, Glyceryl Stearate, Beeswax, Cetearyl Olivate, Carbomer, Tromethamine, Sorbitan Olivate, Cetearyl Glucoside, Sodium Acrylate/Sodium Acryloyldimethyltaurate copolymer, polyisobutene, ethylhexylglycerin, beta-glucan, propanediol, sodium hyaluronate, fragrance (menthol), disodium EDTA and lactobacillus/red ginseng fermentation filtrate Each was mixed in an equal weight ratio, put into a beaker, and stirred at 120 rpm for 30 minutes using an Azimixer to prepare a cream formulation.
실험예Experimental example 1. One. 피부미백skin whitening 효과 확인 Check the effect
상기 실시예 1 내지 2, 비교예 1 내지 5 그리고, 제조예 1에서 제조한 조성물에 대하여 피부미백 효과를 확인하였다.The skin whitening effect of the compositions prepared in Examples 1 to 2, Comparative Examples 1 to 5, and Preparation Example 1 was confirmed.
25㎠ T-플라스크에 DMEM 배지(포도당 4.5g/ℓ 89%, 혈청 10%, 항생제 1%) 5∼6㎖를 넣은 후, 동결보관 중인 마우스 유래 B-16 멜라노마(ATCC CRL 6323) 세포주를 접종하여 37℃ 온도, 5% CO2 조건하에서 24시간 동안 배양한 다음, 0.02% EDTA가 함유된 0.05% 트립신을 처리하여 세포를 분리한 후, 25㎠ T-플라스크에 접종하여 48시간동안 배양하였다. 그 결과, 얻어진 세포 수는 플라스크 당 5.76 × 106 cells이었다. 여기에 100μg/㎖의 실시예 1 내지 2, 비교예 1 내지 5 그리고, 제조예 1에서 제조한 조성물을 DMEM 배지에 희석시켜 배양된 멜라노마 세포에 처리하여 37℃에서 5일간 배양하였다. 배양 후 배지를 모두 제거하고, 0.02% EDTA와 0.05% 트립신을 함유한 살린-포스페이트 완충용액(PBS) 1㎖를 처리하여 세포를 분리시킨 후 5분간 원심분리하여 세포만을 수집하였다. 수집된 세포에 5% 트리클로로아세테이트(TCA)를 처리하여 교반하고, 원심분리하여 침전된 멜라닌을 살린-포스페이트 완충 용액으로 세척하였다. 이어서, 침전된 멜라닌에 1N NaOH를 처리하여 용해시킨 후 475nm에서 흡광도를 측정하고, 합성 멜라닌(시그마사)의 표준농도 곡선으로부터 멜라닌의 농도를 결정한 후, 멜라닌 생성 억제율을 하기 표 2에 나타내었다.After adding 5 to 6 ml of DMEM medium (89% glucose 4.5g/L, 10% serum, 1% antibiotics) to a 25cm2 T-flask, cryopreserved mouse-derived B-16 melanoma (ATCC CRL 6323) cell line was frozen. Inoculated and cultured for 24 hours under 37°C temperature and 5% CO 2 conditions, then treated with 0.05% trypsin containing 0.02% EDTA to separate the cells, inoculated into a 25cm2 T-flask and cultured for 48 hours. . As a result, the number of cells obtained was 5.76 × 10 6 cells per flask. Here, 100 μg / ml of Examples 1 to 2, Comparative Examples 1 to 5, and the composition prepared in Preparation Example 1 was diluted in DMEM medium, treated with cultured melanoma cells, and cultured at 37 ° C. for 5 days. After culturing, all the medium was removed, and the cells were separated by treatment with 1 ml of saline-phosphate buffer (PBS) containing 0.02% EDTA and 0.05% trypsin, and only the cells were collected by centrifugation for 5 minutes. The collected cells were treated with 5% trichloroacetate (TCA), stirred, centrifuged, and precipitated melanin was washed with a saline-phosphate buffer solution. Subsequently, after dissolving the precipitated melanin by treating it with 1N NaOH, the absorbance was measured at 475 nm, the concentration of melanin was determined from the standard concentration curve of synthetic melanin (Sigma), and the melanin production inhibition rate was shown in Table 2 below.
그 결과, 모든 구성성분이 혼합된 실시예 1과 실시예 2의 피부 미백 효과가 각 구성성분을 단독 처리한 비교예 1 내지 5보다 월등히 높은 수치를 갖는 것이 확인되었으며, 이들의 조합에 따라 예기치 못한 시너지 효과가 나타났음을 확인할 수 있었다. 한편, 실시예 1보다는 실시예 2가 좀 더 높은 미백 효과를 가짐을 확인할 수 있었다.As a result, it was confirmed that the skin whitening effect of Examples 1 and 2, in which all components were mixed, had a significantly higher value than Comparative Examples 1 to 5, in which each component was treated alone, and unexpected It was confirmed that a synergistic effect appeared. On the other hand, it was confirmed that Example 2 had a higher whitening effect than Example 1.
실험예Experimental example 2. 주름개선 효과 확인 2. Check wrinkle improvement effect
상기 실시예 1 내지 2, 비교예 1 내지 5 그리고, 제조예 1에서 제조한 조성물에 대하여 주름개선 효과를 확인하였다.The anti-wrinkle effect of the compositions prepared in Examples 1 to 2, Comparative Examples 1 to 5, and Preparation Example 1 was confirmed.
엘라스타아제는 진피 내 피부 탄력을 유지하는 기질 단백질인 엘라스틴의 분해에 관여하며, 엘라스틴을 분해할 수 있는 비특이적 가수분해효소이다. 또한, 체내의 엘라스틴을 분해하는 백혈구 과립 효소 중의 하나로 이상조직에서는 활성이 높아져 조직파괴의 직접적인 원인이 되며, 피부의 주름 및 탄력성 소실 등을 유발한다. 따라서 엘라스타아제 저해제는 피부의 주름을 개선하는 효과가 있다.Elastase is involved in the decomposition of elastin, a matrix protein that maintains skin elasticity in the dermis, and is a non-specific hydrolase capable of degrading elastin. In addition, it is one of the leukocyte aggregation enzymes that decompose elastin in the body, and its activity is increased in abnormal tissues, which is a direct cause of tissue destruction, and causes wrinkles and loss of elasticity of the skin. Therefore, elastase inhibitors have the effect of improving skin wrinkles.
돼지의 췌장 엘라스타아제(Porcine pancreas elastase) 저해 활성 측정은 기질로서 N-숙시닐-(L-Ala)3-p-나이트로아닐라이드를 사용하여 37℃에서 20분간 p-나이트로아닐라이드의 생성량을 405 nm에서 측정하였다. 즉, 실시예 1 내지 2, 비교예 1 내지 5 그리고, 제조예 1에서 제조한 조성물을 100 ㎍/㎖의 농도가 되도록 조제하여 0.5 ㎖씩 시험관에 취하고 50 mM Tris-HCl 완충액(pH 8.6)에 녹인 엘라스타아제(2.5 U/㎖) 용액 0.5 ㎖를 가한 후 기질로 50 mM Tris-HCl 완충액(pH 8.6)에 녹인 N-숙시닐-(LAla)3-p-나이트로아닐라이드(0.5 mg/㎖)를 첨가하여 20분간 반응시켜 측정하였다. 대조군으로 ursolic acid를 이용하였으며, 결과는 대조군인 ursolic acid와 비교하여 백분율로써 하기 표 3에 나타내었다.Porcine pancreas elastase inhibitory activity was measured using N-succinyl-(L-Ala)3-p-nitroanilide as a substrate at 37°C for 20 minutes by p-nitroanilide The amount of production was measured at 405 nm. That is, the compositions prepared in Examples 1 to 2, Comparative Examples 1 to 5, and Preparation Example 1 were prepared to have a concentration of 100 μg/ml, and 0.5 ml each was taken in a test tube and placed in a 50 mM Tris-HCl buffer (pH 8.6). After adding 0.5 ml of the dissolved elastase (2.5 U/ml) solution, N-succinyl-(LAla)3-p-nitroanilide (0.5 mg/ml) dissolved in 50 mM Tris-HCl buffer (pH 8.6) was used as a substrate. ㎖) was added and reacted for 20 minutes to measure. As a control group, ursolic acid was used, and the results are shown in Table 3 below as a percentage compared to ursolic acid as a control group.
그 결과, 모든 구성성분이 혼합된 실시예 1과 실시예 2의 엘라스타아제 저해 효과가 각 구성성분을 단독 처리한 비교예 1 내지 5보다 월등히 높은 수치를 갖는 것이 확인되었으며, 이들의 조합에 따라 예기치 못한 시너지 효과가 나타났음을 확인할 수 있었다. 한편, 실시예 1보다는 실시예 2가 좀 더 높은 주름개선 효과를 가질 수 있음을 확인할 수 있었다.As a result, it was confirmed that the elastase inhibitory effect of Examples 1 and 2, in which all components were mixed, had a significantly higher value than Comparative Examples 1 to 5, in which each component was treated alone. It was confirmed that an unexpected synergistic effect appeared. On the other hand, it was confirmed that Example 2 can have a higher anti-wrinkle effect than Example 1.
실험예Experimental example 3. 3. 안티폴루션anti-pollution 효과 확인 Check the effect
상기 실시예 1 내지 2, 비교예 1 내지 5 그리고, 제조예 1에서 제조한 조성물에 대하여 안티폴루션 효과를 확인하였다.The anti-pollution effect of the compositions prepared in Examples 1 to 2, Comparative Examples 1 to 5, and Preparation Example 1 was confirmed.
일반적으로 공해 물질과 직접적으로 맞닿게 되는 피부 각질세포를 사용하여 공해물질에 의한 세포 손상 정도를 측정하고, 실시예 1 내지 2, 비교예 1 내지 5 그리고, 제조예 1에서 제조한 조성물을 처리하고, 피부 세포 손상 억제 효과를 확인하였다. 실험은 공지된 방법에 따라 진행하였다.In general, the degree of cell damage by pollutants is measured using skin keratinocytes that come into direct contact with pollutants, and the compositions prepared in Examples 1 to 2, Comparative Examples 1 to 5, and Preparation Example 1 are treated, , The effect of inhibiting skin cell damage was confirmed. The experiment was conducted according to a known method.
사람 각질 세포 HaCaT를 1×104 cells/ml 농도로 96-well plate에 200 ㎕씩 분주하여 37℃, CO2 인큐베이터에서 24시간 배양하였다. 이때, 배지는 소혈청 10%와 항생제 1%가 포함된 IMDM 배지를 이용하였다. 배양 후 소혈청과 항생제가 배제된 IMDM 배지로 교체한 다음, 벤조피렌(2.5㎍/mL), 질산암모늄(500ppm), 포름알데히드(1.5㎍/mL)를 처리한 후 실시예 1 내지 2, 비교예 1 내지 5 그리고, 제조예 1에서 제조한 조성물을 1000배 희석처리하여 21시간 추가 배양하였다. 그 후 5mg/ml 농도의 MTT solution을 넣고 3시간 배양한 다음, 배지를 제거하고 dimethyl sulfoxide를 150ul 씩 각 well에 넣어주고 10분간 shaking 하고, 570nm로 흡광도를 측정하였다. 오염물을 처리하지 않은 실험군의 세포생존율을 대조군으로 하고, 대조군의 세포증식율을 100%로 하여 실시예 1 내지 2, 비교예 1 내지 5 그리고, 제조예 1에서 제조한 조성물의 세포증식율을 비교하였다. 비교군은 실험군 대신 정제수만을 투입하였다.Human keratinocyte HaCaT was dispensed at a concentration of 1×10 4 cells/ml in 200 µl each in a 96-well plate, and cultured in a CO 2 incubator at 37°C for 24 hours. At this time, IMDM medium containing 10% of bovine serum and 1% of antibiotics was used as the medium. After culturing, the medium was replaced with IMDM medium excluding bovine serum and antibiotics, and then treated with benzopyrene (2.5 μg/mL), ammonium nitrate (500 ppm), and formaldehyde (1.5 μg/mL), and then Examples 1 to 2 and Comparative Example 1 to 5, and the composition prepared in Preparation Example 1 was diluted 1000 times and further cultured for 21 hours. Thereafter, 5 mg/ml MTT solution was added and incubated for 3 hours, then the medium was removed, 150 μl of dimethyl sulfoxide was added to each well, shaken for 10 minutes, and absorbance was measured at 570 nm. The cell growth rates of the compositions prepared in Examples 1 to 2, Comparative Examples 1 to 5, and Preparation Example 1 were compared with the cell viability of the experimental group not treated with contaminants as a control and the cell growth rate of the control group as 100%. In the control group, only purified water was added instead of the experimental group.
그 결과, 모든 구성성분이 혼합된 실시예 1과 실시예 2의 안티폴루션 효과가 각 구성성분을 단독 처리한 비교예 1 내지 5보다 월등히 높은 수치를 갖는 것이 확인되었으며, 이들의 조합에 따라 예기치 못한 시너지 효과가 나타났음을 확인할 수 있었다. 한편, 실시예 1보다는 실시예 2가 좀 더 높은 안티폴루션 효과를 가짐을 확인할 수 있었다.As a result, it was confirmed that the anti-pollution effect of Examples 1 and 2, in which all components were mixed, had a significantly higher value than Comparative Examples 1 to 5, in which each component was treated alone. It was confirmed that a synergistic effect was not found. On the other hand, it was confirmed that Example 2 had a higher anti-pollution effect than Example 1.
본 발명을 첨부된 도면과 함께 설명하였으나, 이는 본 발명의 요지를 포함하는 다양한 실시 형태 중의 하나의 실시 예에 불과하며, 당 업계에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 하는 데에 그 목적이 있는 것으로, 본 발명은 상기 설명된 실시예에만 국한되는 것이 아님은 명확하다. 따라서, 본 발명의 보호범위는 하기의 청구범위에 의해 해석되어야 하며, 본 발명의 요지를 벗어나지 않는 범위 내에서 변경, 치환, 대체 등에 의해 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리에 포함될 것이다. 또한, 도면의 일부 구성은 구성을 보다 명확하게 설명하기 위한 것으로 실제보다 과장되거나 축소되어 제공되는 것임을 명확히 한다.Although the present invention has been described with the accompanying drawings, this is only one example of various embodiments including the gist of the present invention, and is intended to be easily practiced by those skilled in the art. As an object, it is clear that the present invention is not limited to the embodiments described above. Therefore, the protection scope of the present invention should be construed by the following claims, and all technical ideas within the equivalent range by change, substitution, substitution, etc. will be included In addition, it is clear that some configurations in the drawings are provided exaggerated or reduced than the actual ones to more clearly explain the configuration.
Claims (5)
상기 꾸지뽕나무 추출물은 꾸지뽕나무의 껍질 부위를 추출하여 얻어진 꾸지뽕나무껍질 추출물인 것을 특징으로 하는 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물.According to claim 1,
The cosmetic composition containing the kuji mulberry extract as an active ingredient, characterized in that the kuji mulberry extract is an extract of the cudra mulberry bark obtained by extracting the bark of the cudra mulberry tree.
상기 홍삼발효물은 홍삼을 락토바실러스를 이용해 발효하여 여과한 락토바실러스/홍삼발효여과물인 것을 특징으로 하는 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물.According to claim 1,
The red ginseng fermentation product is a cosmetic composition containing as an active ingredient, a lactobacillus / red ginseng fermentation filtrate obtained by fermenting red ginseng using lactobacillus and filtering it.
상기 혼합물은 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물이 각각 0.01 ~ 50.0 : 0.01 ~ 50.0 : 0.01 ~ 50.0의 중량비로 혼합된 것을 특징으로 하는 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물.According to claim 1,
The mixture is a cosmetic composition containing a kuji mulberry extract as an active ingredient, characterized in that the kuji mulberry extract, jojoba seed oil, and red ginseng fermentation filtrate are mixed in a weight ratio of 0.01 to 50.0: 0.01 to 50.0: 0.01 to 50.0, respectively.
상기 꾸지뽕나무 추출물, 호호바씨오일 및 홍삼발효여과물의 혼합물을 포함하여 크림 제형으로 제형화된 것을 특징으로 하는 꾸지뽕나무 추출물을 유효성분으로 함유하는 화장료 조성물.
According to claim 1,
A cosmetic composition containing the Cudrania quince extract as an active ingredient, characterized in that it is formulated into a cream formulation, including a mixture of the Cudrania quince extract, jojoba seed oil and red ginseng fermentation filtrate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210062463A KR102619648B1 (en) | 2021-05-14 | 2021-05-14 | Cosmetic composition containing Cudrania extract as an active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210062463A KR102619648B1 (en) | 2021-05-14 | 2021-05-14 | Cosmetic composition containing Cudrania extract as an active ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220154918A true KR20220154918A (en) | 2022-11-22 |
KR102619648B1 KR102619648B1 (en) | 2023-12-29 |
Family
ID=84236275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210062463A KR102619648B1 (en) | 2021-05-14 | 2021-05-14 | Cosmetic composition containing Cudrania extract as an active ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102619648B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102657790B1 (en) * | 2023-11-23 | 2024-04-17 | 주식회사 뜰꽃 | Cosmetic composition for improving skin elasticity containing natural extracts |
KR102662972B1 (en) * | 2023-11-23 | 2024-05-03 | 주식회사 뜰꽃 | Cosmetic composition for improving neck wrinkles and lip wrinkles |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102201385B1 (en) | 2018-10-11 | 2021-01-11 | 주식회사 그라젬 | Whitening cosmetic compositions and whitening cosmetics using the same |
-
2021
- 2021-05-14 KR KR1020210062463A patent/KR102619648B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102201385B1 (en) | 2018-10-11 | 2021-01-11 | 주식회사 그라젬 | Whitening cosmetic compositions and whitening cosmetics using the same |
Non-Patent Citations (2)
Title |
---|
Journal of medicinal food. 제15권, 제11호, 1015-1023쪽, 2012년 공개* * |
네이버 블로그. 미토피아 RASE219 파이토네츄럴크림. [online], (2010.04.19. 공개)* * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102657790B1 (en) * | 2023-11-23 | 2024-04-17 | 주식회사 뜰꽃 | Cosmetic composition for improving skin elasticity containing natural extracts |
KR102662972B1 (en) * | 2023-11-23 | 2024-05-03 | 주식회사 뜰꽃 | Cosmetic composition for improving neck wrinkles and lip wrinkles |
Also Published As
Publication number | Publication date |
---|---|
KR102619648B1 (en) | 2023-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101353054B1 (en) | fermented product and manufacturing method thereof, food composition cosmetic and compositon | |
KR101502687B1 (en) | Anti-aging and Anti-inflammatory and Anti-oxidant Cosmetic Composition including Beans Placenta Cell Cultures Extracts | |
KR102619648B1 (en) | Cosmetic composition containing Cudrania extract as an active ingredient | |
KR101848881B1 (en) | Cosmetic composition for anti-wrinkle effect having fermented abeliophyllum distichum | |
KR20190091162A (en) | Cosmetic Composition for Improving Skin and Hair Condition Containing Green Tea Leaf Fermentation Extract | |
KR20180048408A (en) | Whitening cosmetics containing the Saururus chinensis (Lour.) Baill. with improved whitening activity by Jeju Shindari fermentation method and producing method thereof | |
KR20170137963A (en) | A Useful Ferment Extract For Anti-inflammatory Activity And Skin Improvement That Fermented Lettuce, Inula flower And Dandelion With Lactic Acid Bacteria And Cosmetic Composition Including The Same | |
CN112933001A (en) | Composition of myrtle extract and surface active substance | |
KR102350857B1 (en) | Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water | |
KR20170011035A (en) | Cosmetic composition for preventing thermal skin aging containing aloe vera leaves complex extract | |
KR101648148B1 (en) | Cosmetic composition containing fermented graviola for improving anti-wrinkle and method of preparing the same | |
KR101854444B1 (en) | A cosmetic composition for the prevention and improvement of striae distensae containing a extract of cynara scolymus | |
KR101960571B1 (en) | Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract | |
KR20160062401A (en) | Cosmetic composition having Anti-aging and anti-wrinkle effect containing wheat sprout extracts | |
KR102202554B1 (en) | Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product | |
KR102171472B1 (en) | a Composition for improving Hair growth containing a leaf extract of Dendropanax Morbifera and a extract of Hallabong rind | |
KR102076655B1 (en) | A cosmetic composition for slimming containing spicule powder and curcuma longa extract | |
KR101957435B1 (en) | Method for preparing extract of fermented silkworm cocoon for improving antiwrinkle and a cosmetic composition containing the fermented extract of silkworm cocoon as an active ingredients | |
CN113631227A (en) | Antiaging agent, antioxidant, antiinflammatory agent, whitening agent, and cosmetic | |
KR101865688B1 (en) | Cosmetic composition comprising extracts of Trachelospermum jasminoides, Coptis chinensis and Sophora Japonica as active ingredient | |
KR101720741B1 (en) | Cosmetic composition comprising pourthiaea vilosa var. brunnea extract | |
KR20150113252A (en) | extract of rice bran reinforced vitamin and cosmetic composition and manufacturing method thereof | |
KR102393811B1 (en) | Composition comprising for whitening of skin containing fermented solution | |
KR102616144B1 (en) | Cosmetic composition for improving skin wrinkles containing eight complex | |
KR102657593B1 (en) | A Cosmetic Composition for Enhancing Function of Skin Barrier with Filaggrin Activity Comprising Hizikia fusiformis Extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |